This review byLeonidas Duntas aims to summarize the current knowledge regarding seleniumdeficiency and excess in pregnancy outcome as well as to briefly describe the challenges and controversies concerning seleniumsupplementation in pregnant women with seleniumdeficiency with or without concomitant thyroid disease.

Authors: Jung Ho Choi, Young Ok Hong, Hyo-Jeong Kim and Ah Ra Jung

Content type: Case report

19 November 2021

Authors: Bastiaan Sol, Bert Bravenboer, Brigitte Velkeniers, Steven Raeymaeckers, Marleen Keyaerts and Corina Emilia Andreescu

Content type: Research

19 October 2021

Authors: Roya Kabodmehri, Seyedeh Hajar Sharami, Ziba Zahiri Sorouri, Nasrin Ghanami Gashti, Forozan Milani, Zeinab Chaypaz and Maryam Ghalandari

Content type: Research

1 October 2021

Authors: Soraya Doustmohammadian, Azam Doustmohammadian and Marjan Momeni

Content type: Review

29 September 2021

Authors: N. V. Dang, L. X. Son, N. T. T. Hong, N. T. T. Nhung, N. T. Tung and L. V. Quang

Content type: Case report

16 August 2021

Most recent articles RSS

View all articles

Authors: Theodore T Zava and David T Zava

Content type: Review

5 October 2011

Authors: Adam Gesing, Andrzej Lewi艅ski and Ma艂gorzata Karbownik-Lewi艅ska

Content type: Review

24 November 2012

Authors: Agata Bielecka-Dabrowa, Dimitri P Mikhailidis, Jacek Rysz and Maciej Banach

Content type: Review

2 April 2009

Authors: Tim I. M. Korevaar

Content type: Commentary

21 May 2018

Authors: Anca Staii, Sarah Mirocha, Kristina Todorova-Koteva, Simone Glinberg and Juan C Jaume

Content type: Research

20 December 2010

Most accessed articles RSS

View all articles

Thyroid Research is an online journal that aims to present the newest knowledge related to thyroid hormones, thyroid diseases and any related fields. The journal鈥檚 regular readership includes researchers, clinicians and healthcare providers across the world.

Thyroid Research encompasses a wide range of thyroidology topics including, diagnosis, pharmacological and other treatment methods, invasive treatment, physiological mechanisms of thyroid hormone action and regulation, immunological aspects, genetics, new guidelines in disease management, thyroid related diseases and complications.

Prof Bijay Vaidya
Editor-in-Chief
Bijay Vaidya is Consultant Endocrinologist at the Royal Devon Exeter Hospital, and Honorary Clinical Professor at the University of Exeter Medical School, United Kingdom. He obtained his MBBS degree from the Darbhanga Medical College, Darbhanga, India and a PhD from the University of Newcastle upon Tyne, United Kingdom. He has clinical and research interest in thyroid diseases, particularly thyroid disorders in pregnancy. He has served as Treasurer and an Executive Committee Member of the British Thyroid Association, and is a member of the Clinical Committeee of the UK Society for Endocrinology and the Thyroid Eye Disease Amsterdam Declaration Implementation Group UK (TEAMeD UK). He has served on the ETA Guidelines Task Forces for 鈥楴on-autoimmune hyperthyroidism due to TSHR mutations鈥?and 鈥楽ubclinical hypothyroidism in pregnant women and children鈥?and the Royal College of Physicians Guidelines Task Force for 鈥楳anagement of Thyroid Eye Disease鈥? Prof Vaidya has co-authored over 100 papers in peer-reviewed journals.

Simone de Leo
Editor-in-Chief
Simone de Leo graduated in Medicine and completed his fellowship in Endocrinology and Metabolic Diseases at the University of Milan under the guidance of Prof Luca Persani and Laura Fugazzola. During 2015 and 2016, he spent 18 months at Boston University where he worked as a research fellow supervised by Dr Lewis Braverman and Elizabeth Pearce and he was involved in studies about iodine deficiency, Graves鈥?disease, and thyroid disease in pregnancy.Currently he works as an Endocrinologist at the Istituto Auxologico Italiano of Milan and his research is focused on thyroid cancer. He published epidemiological, clinical, and molecular studies on this topic and he was an investigator in several clinical trials of TKIs, such as Lenvatinib, Vandetanib, Cabozantinib, and Selpercatinib. Since September 2018, he is a member of the Executive Committee and of the Website and Social Media Board of the European Thyroid Association.He participated and was invited to several national and international meetings, and won a poster contest at the Associazione Italiana della Tiroide meeting in 2012, the 15^th International Thyroid Congress Trainee Grant Program in 2015, and the Presidential Poster Competition at the Endocrine Society in 2016.

Advertisement